Skip to main content
For full functionality of this page it is necessary to enable JavaScript. Here are the
instructions how to enable JavaScript in your web browser
User menu
Log in
Register
Main menu
Pfizer Products
Therapy Areas
Search form
Search
Pfizer Home
Prevenar 13® Home
Clinical Information
Burden Of Adult Pneumococcal Disease
Prevention of Pneumococcal Disease
Prevenar13 Clinical experience
Efficacy of Prevenar 13
Effectiveness of Prevenar 13
Indian Clinical Trials
Need for Pneumococcal Vaccination
Cost Effectiveness of PCV13
Recommendations for use
Support & Services
Summary of Prescribing Information
FAQ - All Specialties
Conclusion
Downloadable Resources
Events and Webinars
FAQ – PCV13 in Cardiology
FAQ – PCV13 in Diabetes
FAQ – PCV13 in HIV-infection
FAQ – PCV13 in Nephrology
FAQ – PCV13 in Oncology
FAQ – PCV13 in Pulmonology
FAQ – PCV13 in Rheumatology
Videos
Prevenar 13 ® (PCV13: Pneumococcal conjugate vaccine 13-valent) : Protecting Adults 18 Years* or Older From Pneumococcal Disease. *Adapted from: Prevenar 13- PFS, SDV,MDV- GDMS version 2, LPD no. LPDPRV052021 – India
Prevenar 13® Home
Clinical Information
Burden Of Adult Pneumococcal Disease
Prevention of Pneumococcal Disease
Prevenar13 Clinical experience
Efficacy of Prevenar 13
Effectiveness of Prevenar 13
See all >
Click here for Doctor’s Video
Support & Services
Summary of Prescribing Information
FAQ - All Specialties
Conclusion
Downloadable Resources
Events and Webinars
See all >
Click Here for Prevenar 13 Events and Webinars
Images for representation purpose only
PP-PNA-IND-0556, 12th Feb 2021
Data as on January 2020